In clinical trials, receiving probiotics has led to the successful control of the immunologic outcomes of allergy (total and allergen specific IgE, leukocyte counts, blood and nasal eosinophils, Th2/Th1 ratio, IL-4 level, thymus-and activation-regulated chemokines, and quality of life). The gene discussed is IL4; the disease is allergic disease.